DermaProtect est une application web alimentée par l'IA conçue pour aider les individus à gérer la dermatillomanie (grattage compulsif de la peau). En utilisant la webcam de votre appareil, elle emploie la vision par ordinateur pour détecter les comportements de toucher du visage en temps réel et fournit des alertes personnalisables pour vous aider à briser l'habitude. L'outil est basé sur la recherche dermatologique, y compris des études soutenues par le CSIRO, offrant une approche scientifiquement validée pour soutenir votre parcours cutané.
OpenSynaps est une plateforme de bien-être numérique alimentée par l'IA, offrant des programmes personnalisés pour combattre le stress, l'anxiété, les phobies et les addictions. Elle combine l'hypnose, la sophrologie, la méditation et une communauté bienveillante pour aider les utilisateurs à retrouver sérénité et équilibre. L'IA adapte les programmes aux besoins individuels pour une expérience thérapeutique véritablement personnelle.
Aperçu du produit
DermaProtect Aperçu du produit
DermaProtect est une application web alimentée par l'IA conçue pour aider les individus à gérer la dermatillomanie (grattage compulsif de la peau). En utilisant la webcam de votre appareil, elle emploie la vision par ordinateur pour détecter les comportements de toucher du visage en temps réel et fournit des alertes personnalisables pour vous aider à briser l'habitude. L'outil est basé sur la recherche dermatologique, y compris des études soutenues par le CSIRO, offrant une approche scientifiquement validée pour soutenir votre parcours cutané.
OpenSynaps Aperçu du produit
OpenSynaps est une plateforme de bien-être numérique alimentée par l'IA, offrant des programmes personnalisés pour combattre le stress, l'anxiété, les phobies et les addictions. Elle combine l'hypnose, la sophrologie, la méditation et une communauté bienveillante pour aider les utilisateurs à retrouver sérénité et équilibre. L'IA adapte les programmes aux besoins individuels pour une expérience thérapeutique véritablement personnelle.
Detailed feature comparison
| Feature | DermaProtect | OpenSynaps |
|---|---|---|
| Catégorie principale | Vision par ordinateur | Santé Mentale |
| Ajouté | 2025-08-02 | 2025-08-11 |
| Tarification | Payant | Freemium |
| Site officiel | www.dermaprotect.app | opensynaps.com |
| Type de produit | Site web | Site web |
| Performance data | ||
| Note utilisateur | Non vérifié | Non vérifié |
| Commentaires | 0 | 0 |
| Visites mensuelles | 3.4K | 9.5K |
| Croissance mensuelle | Non vérifié | 20% |
| Favoris | 112 | 129 |
| Details | Voir les détails | Voir les détails |
DermaProtect vs OpenSynaps monthly traffic
Compare DermaProtect and OpenSynaps by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the DermaProtect vs OpenSynaps monthly traffic comparison, DermaProtect currently shows 3.4K visits and OpenSynaps shows 9.5K; OpenSynaps has about 2.8 times the visible traffic of DermaProtect, an absolute difference of about 6.1K visits. This reflects visible reach, not feature quality or paid users.
Only OpenSynaps has complete third-party traffic details; DermaProtect uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
DermaProtect monthly traffic:
Latest traffic
OpenSynaps monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 8.2K Visites mensuelles
- 2026/1: 4.8K Visites mensuelles
- 2026/2: 2.7K Visites mensuelles
- 2026/3: 5.3K Visites mensuelles
- 2026/4: 7.9K Visites mensuelles
- 2026/5: 9.5K Visites mensuelles
Principales régions
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇫🇷France | 53.76% | 5.1K |
| 🇪🇸Spain | 27.12% | 2.6K |
| 🇺🇸United States | 19.12% | 1.8K |
Mots-clés
Usage comparison
Compare the core capabilities of DermaProtect and OpenSynaps
DermaProtect Core features
OpenSynaps Core features
Use cases
DermaProtect Use cases
OpenSynaps Use cases
DermaProtect vs OpenSynaps:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth DermaProtect vs OpenSynaps comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. DermaProtect is primarily listed under “Vision par ordinateur”, while OpenSynaps is primarily listed under “Santé Mentale”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (DermaProtect: Vision par ordinateur; OpenSynaps: Santé Mentale); Pricing (DermaProtect: Paid; OpenSynaps: Freemium); Monthly visits (DermaProtect: 3.4K; OpenSynaps: 9.5K); Favorites (DermaProtect: 112; OpenSynaps: 129); Website (DermaProtect: www.dermaprotect.app; OpenSynaps: opensynaps.com). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the DermaProtect vs OpenSynaps monthly traffic comparison, DermaProtect currently shows 3.4K visits and OpenSynaps shows 9.5K; OpenSynaps has about 2.8 times the visible traffic of DermaProtect, an absolute difference of about 6.1K visits. This reflects visible reach, not feature quality or paid users.
Only OpenSynaps has complete third-party traffic details; DermaProtect uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
DermaProtect and OpenSynaps currently overlap in shared categories: Formation d'habitudes; shared tags: Coach IA, santé mentale et bien-être. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
DermaProtect's unique categories/tags are Vision par ordinateur, Santé Mentale, Modification du comportement, BFRB, vision par ordinateur, dermatillomanie, Suivi facial et Suivi d'habitudes; OpenSynaps's are Santé Mentale, Bien-être, anxiété, hypnose, méditation, arrêter de fumer, auto-assistance et Sophrologie. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
DermaProtect has no verified rating, 0 comments, 112 favorites, and 124 likes;OpenSynaps has no verified rating, 0 comments, 129 favorites, and 127 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate DermaProtect first
Put DermaProtect on the priority trial list when the task aligns with “Vision par ordinateur” and especially Vision par ordinateur, Santé Mentale, Modification du comportement, BFRB, vision par ordinateur et dermatillomanie. This follows recorded positioning and does not imply unlisted capabilities are absent.
DermaProtect also currently records: pricing is paid, product type is website, 3.4K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate OpenSynaps first
Put OpenSynaps on the priority trial list when the task aligns with “Santé Mentale” and especially Santé Mentale, Bien-être, anxiété, hypnose, méditation et arrêter de fumer. This follows recorded positioning and does not imply unlisted capabilities are absent.
OpenSynaps also currently records: pricing is freemium, product type is website, 9.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in DermaProtect and OpenSynaps, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




